Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155 · see citing works

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720 · see citing works

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Scher, H. I., Fizazi, K., Saad, F., Taplin, M.-E., Sternberg, C. N., Miller, K., de Wit, R., Mulders, P., Chi, K. N., Shore, N. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207506 · Cited by 4,586 · see citing works

Cancer Metastasis: Building a Framework

Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,230 · see citing works

Genes that mediate breast cancer metastasis to lung

Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · see citing works

A landscape of driver mutations in melanoma

Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · see citing works

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605 · see citing works

A multigenic program mediating breast cancer metastasis to bone

Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,562 · see citing works

Development of a second-generation antiandrogen for treatment of advanced prostate cancer.

Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science · doi:10.1126/science.1168175 · Cited by 2,292 · see citing works

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,177 · see citing works

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

Sosman, J. A., Kim, K. B., Schuchter, L., Gonzalez, R., Pavlick, A. C., Weber, J. S., McArthur, G. A., Hutson, T. E., Moschos, S. J., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112302 · Cited by 2,156 · see citing works

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051 · see citing works

Endogenous human microRNAs that suppress breast cancer metastasis

Tavazoie, S. F., Alarcón, C. R., Óskarsson, T., Padua, D. M., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,858 · see citing works

An oxysterol signalling pathway mediated by the nuclear receptor LXRα

Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,754 · see citing works

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T., et al. (2011) · Nature · doi:10.1038/nature10662 · Cited by 1,454 · see citing works

BrafV600E cooperates with Pten loss to induce metastatic melanoma

Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189 · see citing works

AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective

Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,172 · see citing works

LXR, a nuclear receptor that defines a distinct retinoid response pathway.Preprint

Willy, P. J., Umesono, K., Ong, E. S., Evans, R. M., Heyman, R. A., & Mangelsdorf, D. J. (1995) · Genes & Development · doi:10.1101/gad.9.9.1033 · Cited by 1,124 · see citing works

<i>In vitro</i> Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants

O'Hare, T., Walters, D. K., Stoffregen, E. P., Jia, T., Manley, P. W., Mestan, J., Cowan-Jacob, S. W., Lee, F. Y., Heinrich, M. C., Deininger, M. W. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0259 · Cited by 1,036 · see citing works

Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020 · see citing works

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

Nelson, E. R., Wardell, S., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 805 · see citing works

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., & Tontonoz, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.507 · Cited by 683 · see citing works

Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance

Shi, H., Moriceau, G., Kong, X., Lee, M., Lee, H., Koya, R. C., Ng, C., Chodon, T., Scolyer, R. A., Dahlman, K. B., et al. (2012) · Nature Communications · doi:10.1038/ncomms1727 · Cited by 637 · see citing works

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

Garbe, C., Eigentler, T., Keilholz, U., Hauschild, A., & Kirkwood, J. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0190 · Cited by 581 · see citing works

Treatment of metastatic melanoma: an overview.

Bhatia, S., Tykodi, S. S., & Thompson, J. A. (2009) · PubMed · Cited by 531 · see citing works

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

Png, K. J., Halberg, N., Yoshida, M., & Tavazoie, S. F. (2011) · Nature · doi:10.1038/nature10661 · Cited by 531 · see citing works

Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines

Collins, J. L., Fivush, A. M., Watson, M. A., Galardi, C. M., Lewis, M. C., Moore, L. B., Parks, D. J., Wilson, J. G., Tippin, T. K., Binz, J. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255116 · Cited by 437 · see citing works

Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis

Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., & Tavazoie, S. F. (2012) · Cell · doi:10.1016/j.cell.2012.10.028 · Cited by 415 · see citing works

RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

Yang, H. Y., Higgins, B., Kolinsky, K. D., Packman, K. E., Go, Z., Iyer, R. M., Kolis, S. P., Zhao, S., Lee, R., Grippo, J. F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0646 · Cited by 404 · see citing works

A Novel Orphan Receptor Specific for a Subset of Thyroid Hormone-Responsive Elements and Its Interaction with the Retinoid/Thyroid Hormone Receptor Subfamily

Apfel, R., Benbrook, D., Lernhardt, E., Ortiz, M. A., Salbert, G., & Pfahl, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.7025 · Cited by 372 · see citing works

A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging

Ponomarev, V., Doubrovin, M., Serganova, I. S., Vider, J., Shavrin, A., Beresten, T., Ivanova, A. E., Ageyeva, L., Tourkova, V., Balatoni, J., et al. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1441-5 · Cited by 286 · see citing works

Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors.

Song, C., Kokontis, J. M., Hiipakka, R. A., & Liao, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10809 · Cited by 256 · see citing works

Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages

Mak, P. A., Laffitte, B. A., Desrumaux, C. M., Joseph, S. B., Curtiss, L. K., Mangelsdorf, D. J., Tontonoz, P., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202993200 · Cited by 244 · see citing works

A Nuclear Receptor Atlas: 3T3-L1 Adipogenesis

Fu, M., Sun, T., Bookout, A. L., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0539 · Cited by 233 · see citing works

Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond

Deblois, G., & Giguère, V. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3396 · Cited by 226 · see citing works

Synthetic LXR agonists increase LDL in CETP species

Groot, P. H. E., Pearce, N. J., Yates, J. W., Stocker, C. J., Sauermelch, C. F., Doe, C. P. A., Willette, R. N., Olzinski, A. R., Peters, T., d'Epagnier, D. L., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500116-jlr200 · Cited by 120 · see citing works

Expression Profiling of Nuclear Receptors in the NCI60 Cancer Cell Panel Reveals Receptor-Drug and Receptor-Gene Interactions

Holbeck, S. L., Chang, J., Best, A. M., Bookout, A. L., Mangelsdorf, D. J., & Martinez, E. D. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0040 · Cited by 71 · see citing works

Use of Young Nude Mice for Selection of Subpopulations of Cells With Increased Metastatic Potential From Nonsyngeneic Neoplasms 2 3 4

Pollack, V. A., & Fidler, I. J. (1982) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/69.1.137 · Cited by 41 · see citing works

Use of young nude mice for selection of subpopulations of cells with increased metastatic potential from nonsyngeneic neoplasms.

Pollack, V. A., & Fidler, I. J. (1982) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 8 · see citing works

Harnessing innate immunity in cancer therapy

Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957 · see citing works

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

Demaria, O., Gassart, A. D., Coso, S., Gestermann, N., Domizio, J. D., Flatz, L., Gaide, O., Michielin, O. A., Hwu, P., Petrova, T. V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512832112 · Cited by 574 · see citing works

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

Tavazoie, M. F., Pollack, I., Tanqueco, R., Ostendorf, B. N., Reis, B. S., Gonsalves, F. C., Kurth, I., Andreu-Agullo, C., Derbyshire, M. L., Posada, J., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.026 · Cited by 476 · see citing works

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

Lin, H., Liu, C., Hu, A.-K., Zhang, D., Yang, H., & Mao, Y. Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 424 · see citing works

Lipid metabolism in cancer progression and therapeutic strategies

Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C. J., Zhao, Y., et al. (2020) · MedComm · doi:10.1002/mco2.27 · Cited by 406 · see citing works

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Loeuillard, E. J., Yang, J., Buckarma, E. H., Wang, J., Liu, Y., Conboy, C. B., Pavelko, K. D., Li, Y., O’Brien, D. R., Wang, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137110 · Cited by 370 · see citing works

A framework for the development of effective anti-metastatic agents

Anderson, R. L., Balasas, T., Callaghan, J., Coombes, R. C., EVANS, J., Hall, J. A., Kinrade, S. A., Jones, D., Jones, P. S., Jones, R. J., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0134-8 · Cited by 341 · see citing works

An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers

Villa, G. R., Hulce, J. J., Zanca, C., Bi, J., Ikegami, S., Cahill, G. L., Gu, Y., Lum, K. M., Masui, K., Yang, H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.008 · Cited by 327 · see citing works

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma

Fang, R., Chen, X., Zhang, S., Shi, H., Ye, Y., Shi, H., Zou, Z., Li, P., Guo, Q., Ma, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20379-7 · Cited by 315 · see citing works

The Evolving Landscape of Brain Metastasis

Valiente, M., Ahluwalia, M. S., Boire, A. A., Brastianos, P. K., Goldberg, S. B., Lee, E. Q., Rhun, É. L., Preusser, M., Winkler, F., & Soffietti, R. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.01.003 · Cited by 310 · see citing works

Contradictory roles of lipid metabolism in immune response within the tumor microenvironment

Yu, W., Lei, Q., Yang, L., Qin, G., Liu, S., Wang, D., Ping, Y., & Zhang, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01200-4 · Cited by 272 · see citing works

Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit

Bertero, T., Cottrill, K. A., Lu, Y., Haeger, C. M., Dieffenbach, P. B., Annis, S., Hale, A., Bhat, B., Kaimal, V., Zhang, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.049 · Cited by 232 · see citing works

Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Dysthe, M., & Parihar, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35723-8_8 · Cited by 210 · see citing works

Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer

Bovenga, F., Sabbà, C., & Moschetta, A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.002 · Cited by 209 · see citing works

A PGC1α-mediated transcriptional axis suppresses melanoma metastasis

Luo, C., Lim, J.-H., Lee, Y., Granter, S. R., Thomas, A., Vázquez, F., Widlund, H. R., & Puigserver, P. (2016) · Nature · doi:10.1038/nature19347 · Cited by 205 · see citing works

Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells

Laurette, P., Strub, T., Koludrović, D., Keime, C., Gras, S. L., Seberg, H., Otterloo, E. V., Imrichová, H., Siddaway, R., Aerts, S., et al. (2015) · eLife · doi:10.7554/elife.06857 · Cited by 189 · see citing works

Cholesterol and breast cancer pathophysiology

Nelson, E. R., Chang, C.-Y., & McDonnell, D. P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.10.001 · Cited by 188 · see citing works

Targeting liver X receptors in cancer therapeutics

Lin, C., & Gustafsson, J.-Α. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3912 · Cited by 174 · see citing works

Cholesterol and beyond - The role of the mevalonate pathway in cancer biology

Göbel, A., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188351 · Cited by 167 · see citing works

Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis

Donadon, M., Torzilli, G., Cortese, N., Soldani, C., di Tommaso, L., Franceschini, B., Carriero, R., Barbagallo, M., Rigamonti, A., Anselmo, A., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191847 · Cited by 142 · see citing works

Nuclear receptors: recent drug discovery for cancer therapies.

Zhao, L.-J., Zhou, S.-T., & Gustafsson, J. (2019) · Endocrine reviews · doi:10.1210/er.2018-00222 · Cited by 137 · see citing works

Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?

Vona, R., Iessi, E., & Matarrese, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622908 · Cited by 161 · see citing works

Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review

Proietti, I., Skroza, N., Bernardini, N., Tolino, E., Balduzzi, V., Marchesiello, A., Michelini, S., Volpe, S., Mambrin, A., Mangino, G., et al. (2020) · Cancers · doi:10.3390/cancers12102801 · Cited by 146 · see citing works

Dendrogenin A drives LXR to trigger lethal autophagy in cancers

Segala, G., David, M., de Medina, P., Poirot, M. C., Serhan, N., Vergez, F., Mougel, A., Saland, E., Carayon, K., Leignadier, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01948-9 · Cited by 125 · see citing works

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

Imbert, C., Montfort, A., Fraisse, M., Marcheteau, E., Gilhodes, J., Martin, E., Bertrand, F. A., Marcellin, M., Burlet‐Schiltz, O., de Peredo, A. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14218-7 · Cited by 124 · see citing works

Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines

Valiente, M., Swearingen, A. E. D. V., Anders, C. K., Bairoch, A., Boire, A. A., Bos, P. D., Cittelly, D. M., Erez, N., Ferraro, G. B., Fukumura, D., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0291 · Cited by 123 · see citing works

Reactive Astrocytes in Brain Metastasis

Wasilewski, D., Priego, N., Torre, C. F., & Valiente, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00298 · Cited by 121 · see citing works

Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy

Giacomini, I., Gianfanti, F., Desbats, M. A., Orso, G., Berretta, M., Prayer‐Galetti, T., Ragazzi, E., & Cocetta, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682911 · Cited by 120 · see citing works

CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer

Alfaqih, M. A., Nelson, E. R., Liu, W., Safi, R., Jasper, J. S., Macias, E., Geradts, J., Thompson, J. W., Dubois, L. G., Freeman, M. R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2738 · Cited by 117 · see citing works

Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma

Bertrand, F., Rochotte, J., Colacios, C., Montfort, A., Tilkin-Mariamé, A.-F., Touriol, C., Rochaix, P., Lajoie-Mazenc, I., Andrieu-Abadie, N., Levade, T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2524 · Cited by 113 · see citing works

Common germline variants of the human APOE gene modulate melanoma progression and survival

Ostendorf, B. N., Bilanovic, J., Adaku, N., Tafreshian, K. N., Tavora, B., Vaughan, R. D., & Tavazoie, S. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0879-3 · Cited by 108 · see citing works

Ligands of Therapeutic Utility for the Liver X Receptors

Komati, R., Spadoni, D., Zheng, S., Sridhar, J., Riley, K. E., & Wang, G. (2017) · Molecules · doi:10.3390/molecules22010088 · Cited by 101 · see citing works

Dysregulation of cholesterol metabolism in cancer progression

Liu, X., Lv, M., Zhang, W., & Zhan, Q. (2023) · Oncogene · doi:10.1038/s41388-023-02836-x · Cited by 102 · see citing works

Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR

Gabitova, L., Restifo, D., Gorin, A. A., Manocha, K., Handorf, E. A., Yang, D., Cai, K. Q., Klein–Szanto, A. J., Cunningham, D., Kratz, L. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.023 · Cited by 82 · see citing works

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives

Pellerin, L., Carrié, L., Dufau, C., Nieto, L., Ségui, B., Levade, T., Riond, J., & Andrieu‐Abadie, N. (2020) · Cancers · doi:10.3390/cancers12113147 · Cited by 82 · see citing works

Immunotherapy of targeting MDSCs in tumor microenvironment

Sui, H., Dongye, S., Liu, X., Xu, X., Wang, L., Jin, C. Q., Yao, M., Gong, Z., Jiang, D., Zhang, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.990463 · Cited by 80 · see citing works

The Contribution of Cholesterol and its Metabolites to the Pathophysiology of Breast Cancer

Baek, A., & Nelson, E. R. (2016) · Hormones & cancer · doi:10.1007/s12672-016-0262-5 · Cited by 66 · see citing works

Role of cholesterol homeostasis and its efflux pathways in cancer progression

Sharma, B., & Agnihotri, N. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105377 · Cited by 69 · see citing works

Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1)

Piccinin, E., Cariello, M., & Moschetta, A. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100933 · Cited by 67 · see citing works

A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions

Bertero, T., Cottrill, K. A., Annis, S., Bhat, B., Gochuico, B. R., Osorio, J. C., Rosas, I. O., Haley, K. J., Corey, K. E., Chung, R. T., et al. (2015) · Scientific Reports · doi:10.1038/srep18277 · Cited by 65 · see citing works

Emerging role of liver X receptors in cardiac pathophysiology and heart failure

Cannon, M. V., van Gilst, W. H., & de Boer, R. A. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0520-7 · Cited by 63 · see citing works

Immunomodulatory‐Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor Immunotherapy

Qiu, W., Su, W., Xu, J., Liang, M., Ma, X., Xue, P., Kang, Y., Sun, Z., & Xu, Z. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201233 · Cited by 63 · see citing works

A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment

Hofer, F., Sario, G. D., Musiu, C., Sartoris, S., Sanctis, F. D., & Ugel, S. (2021) · Cells · doi:10.3390/cells10102700 · Cited by 59 · see citing works

Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma

Wu, L., Li, L., Li, S., Liu, L., Xin, W., Li, C., Yin, X., Xu, X., Bao, F., & Hua, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.006 · Cited by 63 · see citing works

Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities

Jiang, W. G., Jin, W., & Xu, A. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.92274 · Cited by 65 · see citing works

Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research.

Bhatia, P., Friedlander, P. L., Elmageed, Z. A., & Kandil, E. H. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2014.12.05 · Cited by 61 · see citing works

LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer

Rudalska, R., Harbig, J., Snaebjornsson, M. T., Klotz, S., Zwirner, S., Taranets, L., Heinzmann, F., Kronenberger, T., Förster, M., Cui, W., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00168-3 · Cited by 59 · see citing works

Host CYP27A1 expression is essential for ovarian cancer progression.

He, S.-S., Ma, L., Baek, A., Vardanyan, A., Vembar, V., Chen, J. J., Nelson, A. T., Burdette, J. E., & Nelson, E. R. (2019) · Endocrine-Related Cancer · doi:10.1530/erc-18-0572 · Cited by 49 · see citing works

Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy

Li, Q., & Xiang, M. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00776-4 · Cited by 54 · see citing works

The Medicinal Chemistry of Liver X Receptor (LXR) Modulators

Tice, C. M., Noto, P. B., Fan, K. Y., Zhuang, L., Lala, D. S., & Singh, S. B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500442z · Cited by 53 · see citing works

25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells

Chen, L., Zhang, L., Xian, G., Lv, Y., Lin, Y., & Wang, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.003 · Cited by 52 · see citing works

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?

Smith, L. K., Arabi, S., Lelliott, E. J., McArthur, G. A., & Sheppard, K. E. (2020) · Cancers · doi:10.3390/cancers12061583 · Cited by 53 · see citing works

Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

Montfort, A., Bertrand, F. A., Rochotte, J., Gilhodes, J., Filleron, T., Milhès, J., Dufau, C., Imbert, C., Riond, J., Tosolini, M., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0342 · Cited by 52 · see citing works

Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions

Laka, K., Makgoo, L., & Mbita, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.841639 · Cited by 51 · see citing works

Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition

Nguyen, T. T. T., Ishida, C. T., Shang, E., Shu, C., Torrini, C., Zhang, Y., Bianchetti, E., Sanchez‐Quintero, M. J., Kleiner, G., Quinzii, C. M., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910769 · Cited by 50 · see citing works

Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment

Carbó, J. M., León, T. E., Font-Díaz, J., de la Rosa, J. V., Castrillo, A., Picard, F. S. R., Staudenraus, D., Huber, M., Cedó, L., Escolá‐Gil, J. C., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3360 · Cited by 50 · see citing works

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 53 · see citing works

The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression

Li, M., Jiang, P., Wei, S., Wang, J., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113312 · Cited by 50 · see citing works

Targeting cholesterol homeostasis in hematopoietic malignancies

Brendolan, A., & Russo, V. E. A. (2021) · Blood · doi:10.1182/blood.2021012788 · Cited by 48 · see citing works

Recent Advances in the Medicinal Chemistry of Liver X Receptors.

Elgendy, B., Goher, S. S., Hegazy, L., Arief, M., & Burris, T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00045 · Cited by 46 · see citing works

Sterol Metabolism and Transport in Atherosclerosis and Cancer

Yamauchi, Y., & Rogers, M. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00509 · Cited by 48 · see citing works

Preparation and characterization of new zinc(II) phthalocyanine — Containing poly(l-lactide)-b-poly(ethylene glycol) copolymer micelles for photodynamic therapy

Lamch, Ł., Kulbacka, J., Pietkiewicz, J., Rossowska, J., Dubińska–Magiera, M., Choromańska, A., & Wilk, K. A. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.04.018 · Cited by 47 · see citing works

Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy

Wan, D., Yang, Y., Liu, Y., Cun, X., Li, M., Xu, S., Zhao, W., Xiang, Y., Qiu, Y., Yu, Q., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.011 · Cited by 45 · see citing works

Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development

Font-Díaz, J., Jiménez‐Panizo, A., Caelles, C., Vivanco, M. D., Pérez, P., Aranda, A., Estébanez‐Perpiñá, E., Castrillo, A., Ricote, M., & Valledor, A. F. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.007 · Cited by 45 · see citing works

Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies

Nitsche, L., Mukherjee, S., Cheruvu, K., Krabak, C., Rachala, R., Ratnakaram, K., Sharma, P., Singh, M., & Yendamuri, S. (2022) · Cancers · doi:10.3390/cancers14061440 · Cited by 45 · see citing works

Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression

Kaneko, T., Kanno, C., Ichikawa‐Tomikawa, N., Kashiwagi, K., Yaginuma, N., Ohkoshi, C., Tanaka, M., Sugino, T., Imura, T., Hasegawa, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5428 · Cited by 44 · see citing works

The emerging roles of liver X receptors and their ligands in cancer

Lin, C.-Y., Vedin, L.-L., & Steffensen, K. (2016) · Expert opinion on therapeutic targets · doi:10.1517/14728222.2015.1081169 · Cited by 40 · see citing works

Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy

Wang, J., & Ilyas, S. I. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1865308 · Cited by 38 · see citing works

Nuclear Receptors in Cancer Inflammation and Immunity

Zhao, L., Hu, H., Gustafsson, J.-Α., & Zhou, S. (2020) · Trends in Immunology · doi:10.1016/j.it.2019.12.006 · Cited by 36 · see citing works

A common transcriptional mechanism involving R-loop and RNA abasic site regulates an enhancer RNA of APOE

Watts, J. A., Grunseich, C., Rodriguez, Y., Liu, Y., Li, D., Burdick, J. T., Bruzel, A., Crouch, R. J., Mahley, R. W., Wilson, S. H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1107 · Cited by 37 · see citing works

Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis

Feng, K., Ma, C., Liu, Y., Yang, X., Yang, Z., Chen, Y., Xu, T., Yang, C., Zhang, S., Li, Q., et al. (2021) · Theranostics · doi:10.7150/thno.53139 · Cited by 35 · see citing works

The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer

McDonnell, D. P., Chang, C.-Y., & Nelson, E. R. (2014) · Climacteric · doi:10.3109/13697137.2014.966949 · Cited by 33 · see citing works

Exploring the biophysical properties of phytosterols in the plasma membrane for novel cancer prevention strategies

Fakih, O., Sanver, D., Kane, D., & Thorne, J. L. (2018) · Biochimie · doi:10.1016/j.biochi.2018.04.028 · Cited by 33 · see citing works

Liver X receptors as potential targets for cancer therapeutics (Review)

Ju, X., Huang, P., Chen, M., & Wang, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.7259 · Cited by 32 · see citing works

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR

Shao, W., Zhu, W., Lin, J., Luo, M., Lin, Z., Lu, L., Jia, H., Qin, L., Lü, M., & Chen, J. (2019) · Neoplasia · doi:10.1016/j.neo.2019.08.002 · Cited by 30 · see citing works

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

Miller, A. L., Garcia, P. L., Fehling, S. C., Gamblin, T. L., Vance, R. B., Chen, D., Yang, E. S.-H., van Waardenburg, R. C. A. M., & Yoon, K. J. (2021) · Cancers · doi:10.3390/cancers13143470 · Cited by 30 · see citing works

Lung cancer and obesity: A contentious relationship (Review)

GEORGAKOPOULOU, V. E., Lempesis, I. G., Τράκας, Ν., Sklapani, P., He, Y., & Spandidos, D. A. (2024) · Oncology Reports · doi:10.3892/or.2024.8817 · Cited by 30 · see citing works

Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB

de la Aleja, A. G., Herrero, C., Torres‐Torresano, M., Schiaffino, M. T., del Castillo, A., Alonso, B., Vega, M. A., Puig‐Kröger, A., Castrillo, A., & Corbí, A. L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04745-4 · Cited by 27 · see citing works

Liver X receptor as a drug target for the treatment of breast cancer

Wu, Y., Yu, D., Yan, D., Hu, Y., Chen, D., Liu, Y., Zhang, H.-D., Yu, S., Cao, H.-X., & Feng, J. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000348 · Cited by 27 · see citing works

Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes

Yin, K., & Smith, A. G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2329-4 · Cited by 27 · see citing works

Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice

Wang, Q., Sun, L., Yang, X., Ma, X., Li, Q., Chen, Y., Liu, Y., Zhang, D., Li, X., Xiang, R., et al. (2016) · Scientific Reports · doi:10.1038/srep27295 · Cited by 26 · see citing works

Discovery of new LXRβ agonists as glioblastoma inhibitors

Chen, H., Chen, Z., Zhang, Z., Li, Y., Zhang, S.-S., Jiang, F., Wei, J., Ding, P., Zhou, H., Gu, Q., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112240 · Cited by 26 · see citing works

Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis

More, S., Bonnereau, J., Wouters, D., Spotbeen, X., Karras, P., Rizzollo, F., Killian, T., Venken, T., Naulaerts, S., Vervoort, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp6164 · Cited by 25 · see citing works

Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy

Lau, E., Šedý, J. R., Sander, C., Shaw, M. A., Feng, Y., Scortegagna, M., Claps, G., Robinson, S. E., Cheng, P. F., Srivas, R., et al. (2015) · Oncogene · doi:10.1038/onc.2015.22 · Cited by 25 · see citing works

Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities

Ramalingam, P. S., Elangovan, S., Ramaiah, M. J., & Arumugam, S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1386102 · Cited by 25 · see citing works

Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression

Blacklock, K. B., Birand, Z., Selmic, L. E., Nelissen, P., Murphy, S., Blackwood, L., Bass, J., McKay, J., Fox, R. I., Beaver, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42839-x · Cited by 26 · see citing works

Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells

Xiong, H., Zhang, Y., Chen, S., Ni, Z., He, J., Li, X., Li, B., Zhao, K., Yang, F., Zeng, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19321 · Cited by 24 · see citing works

Enzymatic Inactivation of Oxysterols in Breast Tumor Cells Constraints Metastasis Formation by Reprogramming the Metastatic Lung Microenvironment

Moresco, M. A., Raccosta, L., Corna, G., Maggioni, D., Soncini, M., Bicciato, S., Doglioni, C., & Russo, V. E. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02251 · Cited by 24 · see citing works

Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold

Goher, S. S., Griffett, K., Hegazy, L., Elagawany, M., Arief, M. M. H., Avdagic, A., Banerjee, S., Burris, T. P., & Elgendy, B. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.025 · Cited by 24 · see citing works

Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors

Nguyen, T. T. T., Ishida, C. T., Shang, E., Shu, C., Bianchetti, E., Karpel‐Massler, G., & Siegelin, M. D. (2019) · Cancers · doi:10.3390/cancers11060788 · Cited by 23 · see citing works

EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality

Chen, T., Xu, J., & Fu, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01688 · Cited by 23 · see citing works

Cholesterol metabolites and tumor microenvironment: the road towards clinical translation

Raccosta, L., Fontana, R., Corna, G., Maggioni, D., Moresco, M. A., & Russo, V. E. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1779-0 · Cited by 23 · see citing works

Engineering strategies of sequential drug delivery systems for combination tumor immunotherapy

Xu, Z., Liu, S., Li, Y., Wu, Y., Tu, J., Chen, Q., & Sun, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.039 · Cited by 22 · see citing works

Suppression of Ca2+ signaling enhances melanoma progression

Gross, S., Hooper, R., Tomar, D., Armstead, A. P., Shanas, N., Mallu, P., Joshi, H., Ray, S., Chong, P. L., Astsaturov, I. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021110046 · Cited by 19 · see citing works

Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma

Hutchinson, P. E., & Pringle, J. H. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13040 · Cited by 19 · see citing works

NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma

Vegliante, M. C., Mazzara, S., Zaccaria, G. M., Summa, S. D., Esposito, F., Melle, F., Motta, G., Sapienza, M. R., Opinto, G., Volpe, G., et al. (2022) · Hematological Oncology · doi:10.1002/hon.3050 · Cited by 19 · see citing works

Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway

Yuan, B., Shi, K., Zha, J., Cai, Y., Gu, Y., Huang, K., Yue, W., Zhai, Q., Ding, N., Ren, W., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-022-05545-7 · Cited by 20 · see citing works

A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon

Zhang, K.-J., Yin, X., Yang, Y., Li, H., Xu, Y., Chen, L.-Y., Liu, X.-J., Yuan, S., Fang, X.-L., Xiao, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1386 · Cited by 20 · see citing works

Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells

Srivastava, S., Widmann, S., Ho, C., Nguyen, D., Nguyen, A., Premaratne, A., Gustafsson, J.-Α., & Lin, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249622 · Cited by 20 · see citing works

Induction of pyroptosis in colon cancer cells by LXRβ

Rébé, C., Derangère, V., & Ghiringhelli, F. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.970094 · Cited by 21 · see citing works

LXR Agonism Inhibits Metastatic Melanoma through Activation of ApoE

(2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2014-056 · Cited by 3 · see citing works

The melanoma metastasis X ‐factor

Haq, R., & Flaherty, K. T. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12285

Abstract IA05: Small RNAs reveal nuclear hormone receptor targeting as a novel therapy for melanoma

Tavazoie, S. F. (2015) · Cancer Research · doi:10.1158/1538-7445.mel2014-ia05

Liver X receptor marks the spot

Osherovich, L. Z. (2014) · Science-Business eXchange · doi:10.1038/scibx.2014.243

Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway

Zhang, W., Jiang, H., Zhang, J., Zhang, Y., Liu, A., Yaozhong, Z., Zhu, X., Lin, Z., & Yuan, X. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-16 · Cited by 30 · see citing works